Results 161 to 170 of about 80,546 (217)

Impaired hematopoiesis affects apheresis and CAR T‐cell product composition and treatment response

open access: yesTransfusion, Volume 66, Issue 7, Page 1375-1389, July 2026.
Abstract Background Chimeric antigen receptor (CAR) T‐cell therapy has transformed the treatment of hematologic malignancies, but its success depends on obtaining sufficient CD3+ T‐cell yields during leukapheresis. This can be difficult in heavily pretreated patients, who often show leukopenia and reduced T‐cell fitness.
Hanna Kuhn   +14 more
wiley   +1 more source

Process Safety Assessment of the Iron-Catalyzed 1,2-<i>cis</i>-Selective Glycal Aminoglycosylation. [PDF]

open access: yesOrg Process Res Dev
Zhang D   +5 more
europepmc   +1 more source

Deletion of Core 1 β3GalT-specific molecular chaperone (Cosmc) in murine intestinal epithelia leads to major alterations in glycocalyx and tumorigenesis. [PDF]

open access: yesJ Biol Chem
Ju T   +11 more
europepmc   +1 more source

Retreatment with talquetamab and pomalidomide in triple‐class–BCMA–GPRC5D refractory myeloma

open access: yes
British Journal of Haematology, Volume 209, Issue 1, Page 320-323, July 2026.
Kian J. Rahbari   +4 more
wiley   +1 more source

Home - About - Disclaimer - Privacy